LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global insulinoma treatment market to grow at a CAGR of over 3% during the forecast period, according to their latest market research report.

SEATTLE -- Adding beta-hydroxybutyrate (BHB) stopping criteria cut down fasting time when detecting insulinomas in patients with hypoglycemia, according to late-breaking findings presented here. By ...

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) may be a less invasive alternative to resection of pancreatic insulinomas in patients ineligible for or who refuse surgery. Surgical ...

Background. A 41-year-old Maltese woman with a 12-month history of severe, morning episodes of confusion, blurred vision and sweating was referred to a specialist center for evaluation of fasting ...

Epilepsy has a high rate of false-positive diagnoses. 1 Seizures may be mimicked by several conditions including syncope, psychogenic nonepileptic seizures (PNESs), and hypoglycemia. Insulinoma is an ...

Chinese researchers have identified the recurrent T372R mutation in the transcription factor YY1 (Yin Yang 1) are related with insulinoma oncogenesis, implicating a potential marker for the diagnosis ...

Stefan King is embarking on a fundraiser in memory of his brother-in-law who died of a rare neuroendocrine tumor of the ...

' I 'HE occurrence of a functioning islet-cell tumor -1- of the pancreas in a patient with diabetes mellitus is an exceedingly rare phenomenon. We have recently studied a patient who demonstrated a ...

Management of refractory hypoglycemia due to malignant insulinoma is challenging. Currently available treatments include dietary modification, diazoxide, and, in patients with resistant disease, the ...